Showing results (201-210 of 225) with videos related to
Sort By:
Pageof 23
The Journal of Biological Chemistry|August 25, 1976
Cyclic adenosine 3':5'-monophosphate phosphodiesterase. Distinct forms in human lymphocytes and monocytesW J Thompson, C P Ross, W J Pledger, et al.Biochimica Et Biophysica Acta|December 8, 1978
Activation of mammalian cyclic AMP phosphodiesterases by trypsinP M Epstein, W J Pledger, E A Gardner, et al.The American Journal of Physiology|July 1, 1997
Ca(2+)-inhibitable adenylyl cyclase and pulmonary microvascular permeabilityP M Chetham, H A Guldemeester, N Mons, et al.Cancer Research|July 26, 2000
Exisulind induction of apoptosis involves guanosine 3',5'-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-cateninW J Thompson, G A Piazza, H Li, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|August 1, 1994
Reversal of pulmonary capillary ischemia-reperfusion injury by rolipram, a cAMP phosphodiesterase inhibitorJ W Barnard, A F Seibert, V R Prasad, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2000
Cyclic GMP mediates apoptosis induced by sulindac derivatives via activation of c-Jun NH2-terminal kinase 1J W Soh, Y Mao, M G Kim, et al.Brain Research. Molecular Brain Research|January 1, 1992
Differential regulation of chromogranin B/secretogranin I and secretogranin II by forskolin in PC12 cellsM E Thompson, W E Zimmer, L B Wear, et al.BMC Cancer|March 7, 2021
The importance of evaluating specific myeloid malignancies in epidemiological studies of environmental carcinogensK A Mundt, L D Dell, P Boffetta, et al.The American Journal of Physiology|May 1, 1995
TNF modulates endothelial properties by decreasing cAMPS Koga, S Morris, S Ogawa, et al.Journal of Medicinal Chemistry|July 23, 1993
Sulfonylmethanesulfonamide inhibitors of carbonic anhydraseT H Scholz, J M Sondey, W C Randall, et al.Pageof 23